Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New AIDS immunotherapeutic in development by Australian company

May 5, 1998

Enzo Biochem receives SBIR grant to support development of AIDS drug

May 5, 1998

Two-vaccine combination for HIV shows promise in clinical trial

May 5, 1998

Gilead prepares orally active prodrugs of PMPA

April 30, 1998

Fasudil hydrochloride inhibits HIV-1 replication in vitro

April 28, 1998

Oxandrin approved in South Korea and the Azerbaijan Republic

April 27, 1998

Novopharm seeks FDA approval to begin phase Ib/II trials with GPI-2A

April 24, 1998

PRO-542 demonstrates potent antiviral activity

April 24, 1998

Clinical data supports efficacy of Panretin capsule formulation in AIDS-related KS

April 22, 1998

Procept allocates funds for further development of PRO-2000

April 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...